Statins and the risk of cancer

JAMA. 2006 Jun 21;295(23):2720; author reply 2721-2. doi: 10.1001/jama.295.23.2720-a.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects*
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / chemistry
  • Neoplasms / chemically induced*
  • Neoplasms / epidemiology
  • Risk

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors